eKonsey Logo
RegisterLogin
Contact live support now for all your inquiries0541 356 67 39
About Us
What is eKonsey?
Our Services
Our Doctors
Conditions
Blog

Prof. Dr., MD Hasan Altunbaş (K)

Prof. Dr., MD Hasan Altunbaş

Prof. Dr. Hasan Altunbaş graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1990) and completed his residency in Internal Medicine (1996) and subspecialty training in Endocrinology and Metabolism (1999) at Akdeniz University Faculty of Medicine. He became assistant professor in 2000, associate professor in 2005, and professor in 2010, serving on the faculty of the Department of Internal Medicine, Division of Endocrinology and Metabolism at Akdeniz University from 2010 to 2019. Since 2019 he has practiced at his private clinic in Antalya.

His clinical interests include thyroid disorders (hypothyroidism, Hashimoto's disease, hyperthyroidism, Graves' disease, nodular goiter, thyroid cancers and thyroiditis), parathyroid disorders, Type 1 and Type 2 diabetes mellitus, overweight and obesity, adrenal disorders (primary hyperaldosteronism, Cushing's syndrome, pheochromocytoma), osteoporosis, vitamin D deficiency, hyperlipidemia, hirsutism, polycystic ovary syndrome (PCOS), and pituitary gland disorders (pituitary adenomas, prolactinoma, acromegaly, pituitary insufficiency).

He has authored 55 articles in international peer-reviewed journals, 41 international conference proceedings, 14 international congress abstracts published in SCI-indexed journals, 30 national journal articles, 92 national conference presentations, and 3 translated book chapters. He served as an investigator in the multicenter national TURDEP-II and TURNEP study groups, and gained research experience at Harvard Medical School's Joslin Diabetes Center in Boston, USA in 2007. He held administrative roles including Head of the Division of Endocrinology and Metabolism at Akdeniz University (2012–2014) and Rector's Advisor (2015–2019).

Education
Tıp Fakültesi (Y. Lisans) ( - 1990)
İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi
Tıpta Uzmanlık — İç Hastalıkları ( - 1996)
Akdeniz Üniversitesi Tıp Fakültesi
Tıpta Uzmanlık — Endokrinoloji ve Metabolizma Hastalıkları ( - 1999)
Akdeniz Üniversitesi Tıp Fakültesi
Experience
Dr. Araştırma Görevlisi (1990 - 1996)
Akdeniz Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı
Uzman Dr. (1996 - 1999)
Akdeniz Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Endokrinoloji ve Metabolizma Bilim Dalı (yan dal uzmanlık eğitimi)
Uzman Dr. (1999 - 2000)
Akdeniz Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Endokrinoloji ve Metabolizma Bilim Dalı
Yrd. Doç. Dr. (2000 - 2005)
Akdeniz Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Endokrinoloji ve Metabolizma Bilim Dalı
Doç. Dr. (2005 - 2010)
Akdeniz Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Endokrinoloji ve Metabolizma Bilim Dalı
Prof. Dr. (2010 - 2019)
Akdeniz Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Endokrinoloji ve Metabolizma Bilim Dalı
Prof. Dr. (2019 - )
Özel Muayenehane, Antalya
Öglisemik hiperinsülinemik klemp tekniği, pankreas adacık antikoru tespiti ve adacık izolasyonu eğitim programı (1997 - 1997)
DETAM, İstanbul Üniversitesi Tıp Fakültesi, İstanbul
Araştırmacı — "Changes in cellular composition of encapsulated islets after transplantation" projesi (2007 - 2007)
Harvard Medical School, Joslin Diabetes Center, Boston, ABD
Articles
  • Uluslararası
    A1. Ündar, L., C. Ertuğrul, H. Altunbaş ve S. Akça, ‘’Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6,’’ Thromb Haemost, 81, 571-575 (1999).
  • Uluslararası
    A2. Altunbaş, H., G. Yazıcıoğlu, M.K. Balcı, Ü. Karayalçın ve L. Ündar, ‘’The use of recombinant human granulocyte colony stimulating factor (G-CSF) in the treatment of propylthiouracil-induced agranulocytosis- a case report,’’ Int J Clin Pract, 53(5), 396-397 (1999).
  • Uluslararası
    A3. Altunbaş, H., Ü. Karayalçın ve L. Ündar, ‘’Glycemic control and coagulation inhibitors in diabetic patients,’’ Haemostasis, 28, 307-312 (1998).
  • Uluslararası
    A4. Arıcı, C., L. Dertsiz, H. Altunbaş, M.K. Balcı, A. Demircan ve K. Emek, ‘’Operative Management of Substernal Goiter: Analysis of 52 patients,’’ Int Surg, 86(4), 220-224 (2001).
  • Uluslararası
    A5. Demir, İ., C. Ermiş, H. Altunbaş ve M.K. Balcı, ‘’Serum HbA1c levels and exercise capacity in diabetic patients,’’ Jpn Heart J, 42(5), 607-616 (2001).
  • Uluslararası
    A6. Gülkesen, K.H., B. Kılıçarslan, H. Altunbaş ve G. Karpuzoğlu, ‘’EGFR and p53 expression and proliferative activity in parathyroid adenomas; an immunohistochemical study,’’ APMIS, 109, 870-874 (2001).
  • Uluslararası
    A7. Arıcı, C., O. Erdogan, H. Altunbaş, A. Boz, M. Melikoğlu, B. Karayalçın ve T. Karpuzoğlu, ‘’Differentiated thyroid carcinoma in children and adolescents: clinical characteristics, treatment and outcome of 15 patients,’’ Horm Res, 57, 153-156 (2002).
  • Uluslararası
    A8. Yılmaz, S., H. Altunbaş, U. Şenol, T. Sindel, A. Mete ve E. Lüleci, ‘’Common peroneal nerve palsy after retrograde popliteal artery puncture,’’ Eur J Vasc Endovasc Surg, 23, 467-469 (2002).
  • Uluslararası
    A9. Çakır, M., H. Altunbaş, M.K. Balcı, Ü. Karayalçın ve G. Karpuzoğlu, ‘’Medullary thyroid carcinoma, follicular variant,’’ End Pathol, 13(1), 75-79 (2002).
  • Uluslararası
    A10. Artaç, M., R. Sarı, H. Altunbaş ve Ü. Karayalçın, ‘’Asymptomatic acute pancreatitis due to tamoxifen-induced severe hypertriglyceridemia in a patient with diabetes mellitus and breast cancer,’’ Journal of Chemotherapy, 214(3), 309-311 (2002).
  • Uluslararası
    A11. Çakır, M., H. Altunbaş ve Ü. Karayalçın, ‘’Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes (letter),’’ The Journal of Clinical Endocrinology and Metabolism, 88(3), 1402-1405 (2003).
  • Uluslararası
    A12. Sarı, R., H. Altunbaş, M. Özdoğan, İ. Gürer ve Ü. Karayalçın, ‘’Severe and prolonged hypoglycemia triggered by long-acting octreotide in a patient with malignant mesenchymal tumor: case report,’’ Journal of Chemotheraphy, 15, 85-88 (2003).
  • Uluslararası
    A13. Altunbaş, H., M.K. Balcı, G. Yazıcıoğlu, E. Semiz, G. Özbilim, Ü. Karayalçın, ‘’Hypocalcemic cardiomyopathy due to untreated hypoparathyroidism,’’ Horm Res, 59, 201-204 (2003).
  • Uluslararası
    A14. Sarı, R., M.K. Balcı, H. Altunbaş ve Ü. Karayalçın, ‘’The effect of body weight and weight loss on thyroid volume and function in obese women,’’ Clinical Endocrinology, 59, 258-262 (2003).
  • Uluslararası
    A15. Altunbaş, H., M.K. Balcı ve Ü. Karayalçın, ‘’No Effect Of Simvastatin Treatment On Insulin Sensitivity In Patients with Primary Hypercholesterolemia,’’ Endocrine Research 29(3), 265-275 (2003).
  • Uluslararası
    A16. Sarı, R., H. Altunbaş, E. Mahsereci, M. Meriç, T. Gelen ve Ü. Karayalçın, ‘’Multiple gastric ulcers caused by gastric candidiasis in a diabetic patient: a rare cause of upper GI bleeding,’’ Gastrointest Endoscopy 58(2), 309-311 (2003).
  • Uluslararası
    A17. Türkay, C., R. Saba, N. Şahin, H. Altunbaş, Ö. Özbudak, B. Akkaya, G. Özbilim, İ. Gölbaşı, M. Türkay ve D. Öğünç, ‘’Effect of chronic pseudomonas aeruginosa infection on the development of atherosclerosis in a rat model,’’ Clinical Microbiology and Infection, 10(8), 705-708 (2004).
  • Uluslararası
    A18. Altunbaş, H., G. Günay, M.K. Balcı, S. Semiz, İ. Bircan ve Ü. Karayalçın, ‘’A patient with thyroid hemiagenesis and Klinefelter's Syndrome,’’ The Endocrinologist 14(3), 119-120 (2004).
  • Uluslararası
    A19. Yazıcıoğlu, G., F. Işıtan, H. Altunbaş, İ. Süleymanlar, M. Özdoğan, Ü. Karayalçın ve M.K. Balcı, ‘’Insulin resistance in chronic hepatitis C,’’ Int J Clin Pract, 58(11), 1020-1022 (2004).
  • Uluslararası
    A20. Bozcuk, H., G. Uslu, M. Samur, M. Yıldız, T. Özben, M. Özdoğan, M. Artaç, H. Altunbaş, İ. Akan ve B. Savaş, ‘’Tumor necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy,’’ Cytokine, 27, 58-65 (2004).
  • Uluslararası
    A21. Sarı, R., M.K. Balcı, M. Çakır, H. Altunbaş ve Ü. Karayalçın, ‘’Comparison of efficacy of sibutramine or orlistat versus their combination in obese women,’’ Endocrine Research, 30(2), 159-167 (2004).
  • Uluslararası
    A22. Çakır, M., E. Mahsereci, H. Altunbaş ve Ü. Karayalçın, ‘’A case of rhabdomyolysis associated with thyrotoxicosis,’’ Journal of The National Medical Association, 97(5), 732-734 (2005).
  • Uluslararası
    A23. Yakupoglu, YK., A. Dinckan, A.Gurkan, M. Tuncer, O. Erdogan, H. Altunbaş, Ü Yakupoglu, R. Sarı ve A.Demirbaş, ‘’Kidney-pancreas transplantation: single center experience at a university hospital in Turkey,’’ Transplant Proc, 37(7), 3205-3208 (2005).
  • Uluslararası
    A24. Çakır, M., C. Arıcı, H. Alakus, H. Altunbas, M.K. Balcı ve Ü. Karayalçın, ‘’Incidental thyroid carcinoma in thyrotoxic patients treated by surgery,’’ Hormone Research, 67(2), 96-9 (2007).
  • Uluslararası
    A25. Şanlıoğlu, AD., T.S. Griffith, A. Ömer, E. Dirice, R. Sarı, H. Altunbas, M.K. Balcı ve S. Şanlıoğlu, ‘’Molecular mechanisms of death ligand-mediated immune modulation: a gene therapy model to prolong islet survival in type 1 diabetes-review,’’ J Cell Biochem, 104(3), 710-20 (2008).
  • Uluslararası
    A26. Sarı, R., H. Altunbaş, M.K. Balcı, H. Akbaş, Ç. Ruhi ve Ü. Karayalçın, ‘’The Effect of thyroid gland palpation and fine needle aspiration biopsy on serum thyroid hormone and thyroglobulin levels,’’ The Endocrinologist, 18(5), 238-240 (2008).
  • Uluslararası
    A27. Kipmen-Korgun, D., S. Bilmen-Sarıkçıoğlu, H. Altunbaş, R. Demir ve E.T. Korgun, ‘’Type-2 diabetes down-regulates glucose transporter proteins and genes of the human blood leukocytes,’’ Scand J Clin Lab Invest, 24, 1-9 (2008).
  • Uluslararası
    A28. Gündoğan, K., F. Bayram, F. Tanrıverdi, A. Karaman, A. Öztürk, H. Altunbaş, C. Gökçe, A. Kalkan ve C. Yazıcı, ‘’Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia,’’ Metab Syndr Relat Disord, 7(5), 427-34 (2009).
  • Uluslararası
    A29. Erbas, T., M.Ertas, A.Yucel, A.Keskinaslan, M.Senocak, TURNEP Study Group (H.Altunbaş), ‘’Prevalence of peripheral neuropathy and painful peripheral neuropathy in Turkish diabetic patients,’’ J Clin Neurophysio, 28(1), 51-55 (2011).
  • Uluslararası
    A30. Cansu, G.B., N.Yılmaz, H.Altunbaş, MK.Balcı, R.Sarı, ‘’Subcutaneous NPH insulin for severe hypertriglyceridemia in a pregnant patient with type V hyperlipoprotenemia: a case report,’’ Balkan Med J 29: 222-224 (2012).
  • Uluslararası
    A31. Şanlıoğlu, AD., H. Altunbaş, MK.Balcı, TS.Griffith, S.Şanlıoğlu, ‘’Insulin gene therapy from design to beta cell generation,’’ Expert Rev Mol Med. 14-18 (2012).
  • Uluslararası
    A32. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, Karsidag K, Genc S, Telci A, Canbaz B, Turker F, Yilmaz T, Cakir B, Tuomilehto J; TURDEP-II Study Group (-H.Altunbaş), ‘’Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults,’’ Eur J Epidemiol 28(2): 169–180 (2013).
  • Uluslararası
    A33. Şanlıoğlu, AD., H.Altunbaş, MK.Balcı, TS.Griffith, S.Şanlıoğlu, ‘’Clinical utility of insulin and insulin analogs,’’ Islets Mar-Apr;5(2):67-78 (2013).
  • Uluslararası
    A34. Taşyürek, MH., H.Altunbaş, MK.Balcı, S.Şanlıoğlu, ‘’Incretins: their physiology and application in the treatment of diabetes mellitus,’’ Diabetes Metabolism Research and Reviews (2013).
  • Uluslararası
    A35. Tasyurek MH, Altunbas HA, Canatan H, Griffith TS, Sanlioglu S, ‘’GLP-1-mediated gene therapy approaches for diabetes treatment,’’ Expert Rev Mol Med. (2014).
  • Uluslararası
    A36. Yilmaz S, Habibi HA, Yildiz A, Altunbas H, ‘’Thyroid Embolization for Nonsurgical Treatment of Nodular Goiter: A Single-Center Experience in 56 Consecutive Patients,’’ J Vasc Interv Radiol. 2021 Oct;32(10):1449-1456.
  • Uluslararası
    A37. Azad A, Altunbas HA, Manguoglu E, ‘’From islet transplantation to beta-cell regeneration: an update on beta-cell-based therapeutic approaches in type 1 diabetes,’’ Expert Rev Endocrinol Metab. 2024 May;19(3):217-227.
  • Uluslararası
    A38. Yilmaz N, Tazegul G, Sari R, Avsar E, Altunbas H, Balci MK, ‘’Effectiveness Of Unilateral Adrenalectomy In Bilateral Adrenal Incidentaloma Patients With Subclinical Hypercortisolemia,’’ Acta Endocrinol (Buchar). 2021 Oct-Dec;17(4):479-485.
  • Uluslararası
    A39. Kargun S, Aydemir M, Yilmaz N, Gürer İE, Sari R, Altunbas H, ‘’An aggressive Cushing's syndrome originating from a rare thymic neuroendocrine tumor, controlled successfully with fluconazole and octreotide therapy before surgery,’’ J Cancer Res Ther. 2025 Jan 1;21(1):251-256.
  • Uluslararası
    A40. Yilmaz N, Avsar E, Tazegul G, Sari R, Altunbas H, Balci MK, ‘’Clinical Characteristics and Follow-Up Results of Adrenal Incidentaloma,’’ Exp Clin Endocrinol Diabetes. 2021 May;129(5):349-356.
  • Uluslararası
    A41. Kahraman S, Yilmaz O, Altunbas HA, Dirice E, Sanlioglu AD, ‘’TRAIL induces proliferation in rodent pancreatic beta cells via AKT activation,’’ J Mol Endocrinol. 2021 May 11;66(4):325-338.
  • Uluslararası
    A42. Tasyurek HM, Altunbas HA, Balci MK, Griffith TS, Sanlioglu S, ‘’Therapeutic Potential of Lentivirus-Mediated Glucagon-Like Peptide-1 Gene Therapy for Diabetes,’’ Hum Gene Ther. 2018 Jul;29(7):802-815.
  • Uluslararası
    A43. Cansu GB, Yılmaz N, Toru S, Sarı R, Gökhan Ocak G, Arıcı C, Altunbaş HA, Balcı MK, ‘’Evaluation of Incidental Thyroid Nodules in Cancer Patients,’’ J Natl Med Assoc. 2017 Winter;109(4):299-306.
  • Uluslararası
    A44. Yilmaz N, Tazegul G, Sari R, Avsar E, Altunbas H, Balci MK, ‘’Effectıveness Of Unılateral Adrenalectomy In Bılateral Adrenal Incıdentaloma Patıents Wıth Subclınıcal Hypercortısolemıa,’’ Acta Endocrinol (Buchar). 2021 Oct-Dec;17(4):479-485.
  • Uluslararası
    A45. Tasyurek HM, Eksi YE, Sanlioglu AD, Altunbas HA, Balci MK, Griffith TS, Sanlioglu S, ‘’HIV-based lentivirus-mediated vasoactive intestinal peptide gene delivery protects against DIO animal model of Type 2 diabetes,’’ Gene Ther. 2018 Jul;25(4):269-283.
  • Uluslararası
    A46. Cansu GB, Atılgan S, Balcı MK, Sarı R, Özdem S, Altunbaş HA, ‘’Which type 2 diabetes mellitus patients should be screened for subclinical Cushing's syndrome?,’’ Hormones (Athens). 2017 Jan;16(1):22-32.
  • Uluslararası
    A47. Cansu Gb, Yılmaz N, Yanıkoğlu A, Özdem S, Yıldırım Ab, Süleymanlar G, Altunbaş HA, ‘’Assessment Of Diastolic Dysfunction, Arterial Stiffness, And Carotid Intima-Media Thickness In Patients With Acromegaly,’’ Endocr Pract. 2017 May;23(5):536-545.
  • Uluslararası
    A48. Tazegul G, Bozoğlan H, Doğan Ö, Sari R, Altunbaş HA, Balci MK, ‘’Cystic lateral neck mass: Thyroid carcinoma metastasis to branchial cleft cyst,’’ J Cancer Res Ther. 2018 Oct-Dec;14(6):1437-1438.
  • Uluslararası
    A49. Boz A, Tazegul G, Bozoglan H, Dogan O, Sari R, Altunbas HA, Arici C, Ocak GA, Balci MK, ‘’Bone metastases without primary tumor: A well-differentiated follicular thyroid carcinoma case,’’ J Cancer Res Ther. 2018 Jan-Mar;14(2):447-450.
  • Uluslararası
    A50. Kargun S, Aydemir M, Yilmaz N, Gürer İE, Sari R, Altunbas H, ‘’An aggressive Cushing's syndrome originating from a rare thymic neuroendocrine tumor, controlled successfully with fluconazole and octreotide therapy before surgery,’’ J Cancer Res Ther. 2025 Jan 1;21(1):251-256.
  • Uluslararası
    A51. Yilmaz N, Tazegul G, Bozoglan H, Sari R, Ozdem S, Altunbas HA, Balci MK, ‘’Diagnostic value of the late-night salivary cortisol in the diagnosis of clinical and subclinical Cushing's syndrome: results of a single-center 7-year experience,’’ J Investig Med. 2019 Jan;67(1):28-33.
  • Uluslararası
    A52. Yilmaz N, Cansu GB, Toru S, Sari R, Ocak GG, Arici C, Altunbas HA, Balci MK, ‘’Cytopathology-histopathology correlation and the effect of nodule diameter on diagnostic performance in patients undergoing thyroid fine-needle aspiration biopsy,’’ J Cancer Res Ther. 2020 Dec;16(Supplement):S53-S58.
  • Uluslararası
    A53. Tazegul G, Ogut TS, Bozoglan H, Dogan O, Yilmaz N, Ulas T, Salim O, Sari R, Altunbas HA, Balci MK, ‘’Using plasma exchange to successfully manage thyrotoxicosis in a patient with possible antithyroid drug-related thrombotic thrombocytopenic purpura,’’ Endocr Regul. 2017 Jul 1;51(3):153-156.
  • Uluslararası
    A54. Erbas T, Ertas M, Yucel A, Keskinaslan A, Senocak M; TURNEP Study Group, ‘’Prevalence of peripheral neuropathy and painful peripheral neuropathy in Turkish diabetic patients,’’ J Clin Neurophysiol. 2011 Feb;28(1):51-5.
  • Uluslararası
    A55. Cansu GB, Yılmaz N, Özdem S, Balcı MK, Süleymanlar G, Arıcı C, Boz A, Sarı R, Altunbaş HA, ‘’Parathyroidectomy in asymptomatic primary hyperparathyroidism reduces carotid intima-media thickness and arterial stiffness,’’ Clin Endocrinol (Oxf). 2016 Jan;84(1):39-47.
  • Uluslararası
    B1. Ündar, L., İ. Karadoğan, H. Altunbaş, S. Akça, C. Ertuğrul ve F. Öztürk, ‘’Circadian variation in plasma beta-thromboglobulin (b-TG) levels in healthy men,’’ Nato Military and Civil 3. Blood Conference, s 96, İstanbul, 1994.
  • Uluslararası
    B2. Ündar, L., İ. Karadoğan, S. Akça, C. Ertuğrul, H. Altunbaş ve F. Öztürk, ‘’Circadian variation in natural coagulation inhibitors protein C, protein S and antithrombin-III in healthy men,’’ XIII. Meeting of The International Society Of Haematology (European and African Division), İstanbul, p 985, 1995.
  • Uluslararası
    B3. Ündar, L., İ. Karadoğan, H. Altunbaş, S. Akça, C. Ertuğrul ve F. Öztürk, ‘’Circadian rhythm of soluble interleukin-2 receptor (sIL-2R) and interleukin-6 (IL-6) in healthy individuals,’’ II. Meeting of the European Haematology Association, Paris, Vol. 93 (suppl 2), 295, British Journal of Haematology, Blackwell Science, 1996.
  • Uluslararası
    B4. Altunbaş, H., Ü. Karayalçın ve L. Ündar, ‘’Effect of metabolic control on coagulation inhibitors in diabetic patients with and without retinopathy,’’ II. Meeting of the European Haematology Association, Paris, Vol. 93 (suppl 2), 15, British Journal of Haematology, Blackwell Science, 1996.
  • Uluslararası
    B5. Ündar, L., İ. Karadoğan, S. Akça, C. Ertuğrul ve H. Altunbaş, ‘’Circadian variation in natural coagulation inhibitors protein C, protein S and antithrombin-III in healthy men,’’ II. Meeting of the European Haematology Association, Paris, Vol. 93 (suppl 2), 6, British Journal of Haematology, Blackwell Science, 1996.
  • Uluslararası
    B6. Ündar, L., İ Karadoğan, H. Altunbaş, S. Akça ve C. Ertuğrul, ‘’Circadian Variation in plasma Β-Thromboglobulin (Β-TG) levels in healthy men,’’ II. Meeting of the European Haematology Association, Paris, Vol. 93 (suppl 2), 6, British Journal of Haematology, Blackwell Science, 1996.
  • Uluslararası
    B7. Altunbaş, H., M.K. Balcı, G. Günay ve Ü. Karayalçın, ‘’A retrospective analysis of diabetic foot patients in Akdeniz University,’’ 9. Balkan Congress of Endocrinology and 24. Panhellenic Congress of Endocrinology and Metabolism, Selanik, s 29, 1997.
  • Uluslararası
    B8. Timurağaoğlu, A., M.K. Balcı, İ. Karadoğan, H. Altunbaş, F. Öztürk, Ü. Karayalçın ve L. Ündar, ‘’Plasma vWF levels correlate with plasma soluble interleukin-2 receptor (sIL-2R) levels in type 2 diabetics with background retinopathy,’’ XVI. Congress of The International Society on Thrombosis and Haemostasis, Floransa, June (suppl), 1-844, Thrombosis and Haemostasis, p 458, 1997.
  • Uluslararası
    B9. Karayalçın, Ü., A. Timurağaoğlu, M.K. Balcı, İ. Karadoğan, H. Altunbaş, ‘’Plasma vWF levels correlate with soluble interleukin-2 receptor (sIL-2R) levels in type 2 diabetics with retinopathy,’’ Helsinki, IDF'97, s 394, 1997.
  • Uluslararası
    B10. Karayalçın, B., A. Özdemir, Ü. Karayalçın, F. Güngör, M.K. Balcı ve H. Altunbaş, ‘’Fixed versus calculated dose radioiodine therapy of solitary toxic nodules,’’ IV. European Congress of Endocrinology, Sevilla, p1-139, 1998.
  • Uluslararası
    B11. Atılgan, S., Ü. Karayalçın, M.K. Balcı, H. Altunbaş, A. Erkılıç ve M. İspir, ‘’The effect of gliclazide on blood pressure and erytrocyte cytosolic calcium in obese, hypertensive patients with impaired glucose tolerance,’’ IV. European Congress of Endocrinology, Sevilla, p1-7, 1998.
  • Uluslararası
    B12. Karadoğan, İ., H. Altunbaş ve L. Ündar, ‘’A unique case of hereditary hemorrhagic telangiectasia and multiple liver cysts,’’ 15th International Congress on Thrombosis, Antalya, Vol. 28 (Suppl 2), Haemostasis, International Journal on Haemostasis and Thrombosis Research, Karger, 1998.
  • Uluslararası
    B13. Altunbaş, H., M.K. Balcı, G. Yazıcıoğlu ve Ü. Karayalçın, ‘’The effect of simvastatin treatment on insulin sensitivity in patients with primary hypercholesterolemia,’’ 19th Joint Meeting of the British Endocrine Societies, with the European Federation of Endocrine Societies, Birmingham, Journal of Endocrinology, Vol. 164 (suppl), p 99, 2000.
  • Uluslararası
    B14. Demir, İ., C. Ermiş, H. Altunbaş, M.K. Balcı ve F. Ersel, ‘’Serum HbA1c levels and exercise capacity in diabetic patients,’’ Turkish-Italian Joint Meeting on Hypertension and Atherosclerosis, Antalya, s 126, 2000.
  • Uluslararası
    B15. Yavuz, H.A., H. Altunbaş, M.K. Balcı, F. Demircioğlu, M. Çakır ve Ü. Karayalçın, ‘’Normal systolic time intervals in subclinical hyperthyroidism,’’ 23rd Congress of Endocrinology and Metabolic Diseases of Turkey Joint Meeting with the European Federation of Endocrine Societies, Ankara, Vol. 23 (suppl. to No.7), p 38, Journal of Endocrinological Investigation, 2000.
  • Uluslararası
    B16. Çakır, M., H. Altunbaş, M.K. Balcı, Ü. Karayalçın ve G. Karpuzoğlu, ‘’Medullary thyroid carcinoma, follicular variant- a case report,’’ 23rd Congress of Endocrinology and Metabolic Diseases of Turkey Joint Meeting with the European Federation of Endocrine Societies, Ankara, Vol. 23 (suppl. to No.7), p 37, Journal of Endocrinological Investigation, 2000.
  • Uluslararası
    B17. Altunbaş, H., M.K. Balcı, A Odabaşoğlu, F. Demircioğlu, M. Kabukçu, O. Sancaktar, M. Çakır ve Ü. Karayalçın, ‘’No relationship between insulin resistance and coronary atherosclerosis diagnosed with coronary angiography,’’ 36th Annual Meeting EASD, Jerusalem, Vol. A 168, p 645, Diabetologia, Springer, 2000.
  • Uluslararası
    B18. Çakır, M., O. Gencel, ND Kaplangı, M.K. Balcı, M. Yardımsever, H. Altunbaş, G. Yazıcıoğlu, R. Sarı ve Ü. Karayalçın, ‘’Revised ceriteria for diagnosing diabetes- rationale or not ?,’’ 5th European Congress of Endocrinology, Turin, p 298, 2001.
  • Uluslararası
    B19. Yazıcıoğlu, G., F. Işıtan, İ. Süleymanlar, H. Altunbaş, M.K. Balcı ve Ü. Karayalçın, ‘’Insulin resistance in chronic hepatitis C patients,’’ 5th European Congress of Endocrinology, Turin, O-087, 2001.
  • Uluslararası
    B20. Sarı, R., G. Yazıcıoğlu, M.K. Balcı, H. Altunbaş, M. Çakır ve Ü. Karayalçın, ‘’Association between calcaneous mineral density by ultrasound and various other parameters,’’ 5th European Congress of Endocrinology, Turin, p 067, 2001.
  • Uluslararası
    B21. Sarı, R., N. Balcı, M. Çakır, M.K. Balcı, H. Altunbaş, G. Yazıcıoğlu, T. Dağseven ve Ü. Karayalçın, ‘’The acute effect of exercise on insulin resistance by homeostasis model assessment in obese women,’’ 24th Congress of Endocrinology and Metabolic Diseases of Turkey, Joint Meeting with the American Association of Clinical Endocrinologists, İstanbul, O-30 p 15, Endocrine Practice suppl, 2001.
  • Uluslararası
    B22. Erbasan, F., M. Çakır, M.K. Balcı, H. Altunbaş, G. Yazıcıoğlu, R. Sarı, A. Timurağaoğlu ve Ü. Karayalçın, ‘’Comparison of thyroid hormonal status and volumes of patients with moderate iron deficiency anemia and normal controls,’’ 24th Congress of Endocrinology and Metabolic Diseases of Turkey, Joint Meeting with the American Association of Clinical Endocrinologists, İstanbul, p 30 s 37, Endocrine Practice suppl, 2001.
  • Uluslararası
    B23. Koyuncu, E., H. Altunbaş, R. Sarı, B. Kılıçaslan, C. Arıcı, M. Çakır, G. Yazıcıoğlu, M.K. Balcı, G. Karpuzoğlu ve Ü. Karayalçın, ‘’A retrospective analysis of patients with primary hyperparathyroidism in Akdeniz University School of Medicine,’’ 24th Congress of Endocrinology and Metabolic Diseases of Turkey, Joint Meeting with the American Association of Clinical Endocrinologists, İstanbul, p 75 s 62, Endocrine Practice suppl, 2001.
  • Uluslararası
    B24. Sarı, R., H. Altunbaş, G. Yazıcıoğlu, M. Çakır, E. Çoban, M.K. Balcı ve Ü. Karayalçın, ‘’The investigation of gallbladder volume and motility by ultrasonography in obese women without gallstones,’’ 24th Congress of Endocrinology and Metabolic Diseases of Turkey, Joint Meeting with the American Association of Clinical Endocrinologists, İstanbul, p 88 s 68, Endocrine Practice suppl, 2001.
  • Uluslararası
    B25. Sarı, R., N. Balcı, M.K. Balcı, M. Çakır, G. Yazıcıoğlu, H. Altunbaş, T. Dağseven ve Ü. Karayalçın, ‘’The effect of exercise on plasma leptin levels in obese women,’’ 24th Congress of Endocrinology and Metabolic Diseases of Turkey, Joint Meeting with the American Association of Clinical Endocrinologists, İstanbul, p 90 s 69, Endocrine Practice suppl, 2001.
  • Uluslararası
    B26. Artaç, M., R. Sarı, H. Altunbaş, G. Yazıcıoğlu, M. Çakır, M.K. Balcı ve Ü. Karayalçın, ‘’Asymptomatic acute pancreatitis due to tamoxifen-induced severe hypertriglyceridemia in a patient with diabetes mellitus,’’ 24th Congress of Endocrinology and Metabolic Diseases of Turkey, Joint Meeting with the American Association of Clinical Endocrinologists, İstanbul, p 92 s 70, Endocrine Practice suppl, 2001.
  • Uluslararası
    B27. Yazıcıoğlu, G., G. Uslu, M.K. Balcı, H. Altunbaş, M. Çakır, R. Sarı ve Ü. Karayalçın, ‘’The effect of atorvastatin on adrenal steroid synthesis in patients with primary hypercholesterolemia,’’ 24th Congress of Endocrinology and Metabolic Diseases of Turkey, Joint Meeting with the American Association of Clinical Endocrinologists, İstanbul, p 113 s 81, Endocrine Practice suppl, 2001.
  • Uluslararası
    B28. Sarı, R., N. Balcı, H. Altunbaş, M.K. Balcı, G. Yazıcıoğlu, M. Çakır ve Ü. Karayalçın, ‘’The effect of exercise on gallbladder volume and motility in obese females without gallstones,’’ 24th Congress of Endocrinology and Metabolic Diseases of Turkey, Joint Meeting with the American Association of Clinical Endocrinologists, İstanbul, p 89 s 69, Endocrine Practice suppl, 2001.
  • Uluslararası
    B29. Uslu, G., H. Altunbaş, M.K. Balcı, M. Çakır, G. Yazıcıoğlu, R. Sarı ve Ü. Karayalçın, ‘’The effect of atorvastatin treatment on insulin sensitivity in patients with primary hypercholesterolemia,’’ 24th Congress of Endocrinology and Metabolic Diseases of Turkey, Joint Meeting with the American Association of Clinical Endocrinologists, İstanbul, p 91 s 70, Endocrine Practice suppl, 2001.
  • Uluslararası
    B30. Tuncer, M., H. Altunbaş, H.A. Yavuz, A. Gürkan, A. Demirbaş, L. Yücetin, G. Yakupoğlu, ‘’Effects of cyclosporin and tacrolimus on peripheral insulin resistance,’’ XXXIX Congress of the European Renal Association European Dialysis and Transplant Association, Kopenhang, Vol. 17 Suppl 1, M465 p 176, Nephrology Dialysis Transplantation, Oxford, 2002.
  • Uluslararası
    B31. Sarı, R., M.K. Balcı, H. Altunbaş, H.S. Akbaş, Ç. Ruhi, Ü. Karayalçın ve N. Cavuslu, ‘’The influence of thyroid palpation and fine needle aspiration on serum thyroid hormones and thyroglobulin,’’ 6th European Congress of Endocrinology, Lyon, p 0941, 2003.
  • Uluslararası
    B32. Alagöz, Z., Ü. Karayalçın, R. Sarı, H. Altunbaş ve M.K. Balcı, ‘’Increase in leptin after isocaloric fasting during Ramadan in non-insulin requiring Type 2 diabetic patients,’’ International Congress of Endocrinology, Lizbon, p 792, 2004.
  • Uluslararası
    B33. Alagöz, Z., Ü. Karayalçın, R. Sarı, H. Altunbaş ve M.K. Balcı, ‘’Positive effect of isocaloric fasting during Ramadan on metabolic control in non-insulin requiring Type 2 diabetic patients,’’ International Congress of Endocrinology, Lizbon, p 794, 2004.
  • Uluslararası
    B34. Sarı, R., M.K. Balcı, E. Çoban, H. Altunbaş ve Ü. Karayalçın, ‘’Comparison of the effect of sibutramine versus sibutramine plus metformin on weight loss in obese women,’’ International Congress of Endocrinology, Lizbon, p 961, 2004.
  • Uluslararası
    B35. Sarı, R., E. Çoban, M.K. Balcı, H. Altunbaş ve Ü. Karayalçın, ‘’The correlation between thyroid volume and body mass index and fat mass in obese women,’’ 13th European Congress on Obesity, Prag, p T6:P6b-019, 2004.
  • Uluslararası
    B36. Tuncer, M., A. Gürkan, O. Erdoğan, H. Altunbaş, Ü. Yakupoğlu, R.Sarı, Y.K. Yakupoğlu, M. Akaydın, F.F. Ersoy, G. Yakupoğlu ve A.Demirbaş, ‘’Pancreas-Kidney Transplantation: Akdeniz University Experience,’’ IXth Congress of the Middle East Society for Organ Transplantation (MESOT), Ankara, O62, 2004.
  • Uluslararası
    B37. Sarı, R., M.K. Balcı, E. Eray, E. Çoban, O. Kolağası, H. Altunbaş ve Ü. Karayalçın, ‘’Comparison of the long-term effect of sibutramine versus sibutramine plus metformin on weight loss and insulin resistance in obese women,’’ 14th European Congress on Obesity (ECO), Atina, Yunanistan, P525 S151 2005.
  • Uluslararası
    B38. Sarı, R., S. Özdem, E. Eray, M. Gültekin, H. Altunbaş ve M.K. Balcı, ‘’Sex hormones and sex hormone-binding globulin in obese women,’’ European Congress of Endocrinology (ECE) 3-7 September 2005, Göteborg, İsveç, P3-268.
  • Uluslararası
    B39. Kipmen-Korgun, D., S. Bilmen-Sarıkçıoğlu, H. Altunbaş, R. Demir ve E.T. Korgun, ‘’Type-2 diabetes down-regulates glucose transporter proteins and genes of the human blood leukocytes,’’ 34th Congress of the Federation-of-European-Biochemical-Societies, Prague, Çek Cumhuriyeti; Febs Journal, vol 276 pages 317-317 Suppl 1 Jul 2009.
  • Uluslararası
    B40. Gurer, IE., SS.Tuncer, GA.Ocak, H.Altunbas, ‘’FNA of thyroid lesions: a brief report,’’ Virchows Archiv vol 461 pages S76 supl 1 2012.
  • Uluslararası
    B41. Merdin A, Balcı MK, Altunbas H, ‘’Case report: thyroid hormone resistance followed up with systolic time interval index measurement,’’ Endo Bridge 2013 (23-26 Ekim 2013, Antalya).
  • Uluslararası
    C1. Ündar L, Karadoğan İ, Altunbaş H, Akça S, Ertuğrul C, Öztürk F, ‘’Circadian rhythm of soluble interleukin-2 receptor (sIL-2R) and interleukin-6 (IL-6) in healthy individuals,’’ II. Meeting of the European Haematology Association, 29 Mayıs-1 Haziran 1996, Paris, Fransa; British Journal of Haematology 1996 93 (suppl 2): 295 (abstract).
  • Uluslararası
    C2. Altunbaş H, Karayalçın Ü, Ündar L, ‘’Effect of metabolic control on coagulation inhibitors in diabetic patients with and without retinopathy,’’ II. Meeting of the European Haematology Association, 29 Mayıs-1 Haziran 1996, Paris, Fransa; British Journal of Haematology 1996 93 (suppl 2): 15 (abstract).
  • Uluslararası
    C3. Ündar L, Karadoğan İ, Akça S, Ertuğrul C, Altunbaş H, ‘’Circadian variation in natural coagulation inhibitors protein C, protein S and antithrombin-III in healthy men,’’ II. Meeting of the European Haematology Association, 29 Mayıs-1 Haziran 1996, Paris, Fransa; British Journal of Haematology 1996 93 (suppl 2) (abstract).
  • Uluslararası
    C4. Ündar L, Karadoğan İ, Altunbaş H, Akça S, Ertuğrul C, ‘’Circadian Variation in plasma β-Thromboglobulin (β-TG) levels in healthy men,’’ II. Meeting of the European Haematology Association, 29 Mayıs-1 Haziran 1996, Paris, Fransa; British Journal of Haematology 1996 93 (suppl 2) (abstract).
  • Uluslararası
    C5. Timurağaoğlu A, Balcı MK, Karadoğan İ, Altunbaş H, Öztürk F, Karayalçın Ü, Ündar L, ‘’Plasma vWF levels correlate with plasma soluble interleukin-2 receptor (sIL-2R) levels in type 2 diabetics with background retinopathy,’’ XVI. Congress of The International Society on Thrombosis and Haemostasis 6-12 Haziran 1997, Florence, İtalya; Thrombosis and Haemostasis 1997 June (suppl): 1-844 (abstract).
  • Uluslararası
    C6. Karadoğan İ, Altunbaş H, Ündar L, ‘’A unique case of hereditary hemorrhagic telangiectasia and multiple liver cysts,’’ 15th International Congress on Thrombosis, 16-21 Ekim 1998, Antalya/Türkiye; Haemostasis, International Journal on Haemostasis and Thrombosis Research 1998, 28 (Suppl)2 (abstract).
  • Uluslararası
    C7. Altunbaş H, Balcı MK, Yazıcıoğlu G, Karayalçın Ü, ‘’The effect of simvastatin treatment on insulin sensitivity in patients with primary hypercholesterolemia,’’ 19th Joint Meeting of the British Endocrine Societies, with the European Federation of Endocrine Societies 13-16 March 2000, Birmingham, İngiltere; Journal of Endocrinology 2000 March 164 (suppl) p 99 (abstract).
  • Uluslararası
    C8. Yavuz HA, Altunbaş H, Balcı MK, Demircioğlu F, Çakır M, Karayalçın Ü, ‘’Normal systolic time intervals in subclinical hyperthyroidism,’’ 23rd Congress of Endocrinology and Metabolic Diseases of Turkey Joint Meeting with the European Federation of Endocrine Societies 7-9 Eylül 2000, Ankara, Türkiye; Journal of Endocrinological Investigation 2000, 23 (suppl. to No.7), ph 38 (abstract).
  • Uluslararası
    C9. Çakır M, Altunbaş H, Balcı MK, Karayalçın Ü, Karpuzoğlu G, ‘’Medullary thyroid carcinoma, follicular variant- a case report,’’ 23rd Congress of Endocrinology and Metabolic Diseases of Turkey Joint Meeting with the European Federation of Endocrine Societies 7-9 Eylül 2000, Ankara, Türkiye; Journal of Endocrinological Investigation 2000, 23 (suppl. to No.7), ph 37 (abstract).
  • Uluslararası
    C10. Altunbaş H, Balcı MK, Odabaşoğlu A, Demircioğlu F, Kabukçu M, Sancaktar O, Çakır M, Karayalçın Ü, ‘’No relationship between insulin resistance and coronary atherosclerosis diagnosed with coronary angiography,’’ 36th Annual Meeting EASD 17-21 Eylül 2000, Jerusalem, İsrail; Diabetologia 2000 abstract volume A 168 p 645.
  • Uluslararası
    C11. Tuncer M, Altunbaş H, Yavuz HA, Gürkan A, Demirbaş A, Yücetin L, Yakupoğlu G, ‘’Effects of cyclosporin and tacrolimus on peripheral insulin resistance,’’ XXXIX Congress of the European Renal Association European Dialysis and Transplant Association 14-17 Temmuz 2002, Kopenhang, Danimarka; Nephrology Dialysis Transplantation vol 17 Abstracts Supplement 1 (2002) M465 p 176.
  • Uluslararası
    C12. Sarı R, Çoban E, Balcı MK, Altunbaş H, Karayalçın Ü, ‘’The correlation between thyroid volume and body mass index and fat mass in obese women,’’ 13th European Congress on Obesity 26-29 Mayıs 2004, Prag, Çek Cumhuriyeti; International Journal of Obesity and Related Metabolic Disorders vol 28 suppl 1 May 2004, abstracts T6: P6b-019 S171.
  • Uluslararası
    C13. Sarı R, Balcı MK, Eray E, Çoban E, Kolağası O, Altunbaş H, Karayalçın Ü, ‘’Comparison of the long-term effect of sibutramine versus sibutramine plus metformin on weight loss and insulin resistance in obese women,’’ 14th European Congress on Obesity (ECO) 1-4 June 2005, Atina, Yunanistan; Obesity Reviews vol 6 supl 1 2005, abstracts P525 S151.
  • Uluslararası
    C14. Kipmen-Korgun, D., S. Bilmen-Sarıkçıoğlu, H. Altunbaş, R. Demir ve E.T. Korgun, ‘’Type-2 diabetes down-regulates glucose transporter proteins and genes of the human blood leukocytes,’’ 34th Congress of the Federation-of-European-Biochemical-Societies, 04-09 Temmuz 2009, Prague, Çek Cumhuriyeti; Febs Journal, vol 276 pages 317-317 Suppl 1 Jul 2009.
  • Ulusal
    D1. Altunbaş, H., Ü. Karayalçın ve G. Süleymanlar, ‘’Addison hastasında rifampisinin indüklediği adrenal kriz,’’ Ulusal Endokrinoloji Dergisi, 6(3), 233-238 (1996).
  • Ulusal
    D2. Altunbaş, H., A. Odabaşoğlu, F. Çiftçi, Z. Önal ve Ü. Karayalçın, ‘’Grand Mal epilepsi ile prezente olan postoperatif hipoparatiroidizm vakası,’’ Ulusal Endokrinoloji Dergisi, 6(2), 161-164 (1996).
  • Ulusal
    D3. Üstün, H., M.Ö. Üstün, M.K. Balcı, H. Altunbaş ve Ü. Karayalçın, ‘’Correlation of thyroid histopatology with fine needle aspiration of thyroid nodules,’’ Medical Journal of Ege University, 8(1-2), 9-11 (1998).
  • Ulusal
    D4. Altunbaş, H., A. Odabaşoğlu, M.K. Balcı, G. Günay, İ. Karadoğan, L. Ündar ve Ü. Karayalçın, ‘’Hiperkolesterolemik Hastalarda Simvastatin'in İn Vitro Trombosit Agregasyonu Üzerine Etkisi,’’ Türkiye Klinikleri Tıp Bilimleri Dergisi, 19, 25-29 (1999).
  • Ulusal
    D5. Altunbaş, H., Ü. Karayalçın, M.K. Balcı ve L. Ündar, ‘’The effect of glycaemic control on fibrinolytic parameters in diabetic patients with or without background retinopathy,’’ T J E M, 1, 1-4 (1999).
  • Ulusal
    D6. Balcı, M.K., A. Timurağaoğlu, H. Altunbaş, Ü. Karayalçın, İ. Karadoğan ve L. Ündar, ‘’Normal Plasma von Willebrand Factor and Thrombomodulin Levels in Turkish Type 2 Diabetic Patients with & without Retinopathy and No Effect of Metabolic Control on These Parameters,’’ T Klin J Med Res, 17, 144-149 (1999).
  • Ulusal
    D7. Altunbaş, H., M.K. Balcı ve Ü. Karayalçın, ‘’A Retrospective Analysis of Hospitalized Diabetic Foot Patients in Akdeniz University School of Medicine, Division of Endocrinology,’’ T J E M, 3, 123-127 (1999).
  • Ulusal
    D8. Timurağaoğlu, A., Ü. Karayalçın, H. Altunbaş, M.K. Balcı, İ. Karadoğan ve L. Ündar, ‘’Plasma von Willebrand Factor (vWF) levels correlate with soluble interleukin-2 receptor (sIL-2R) levels in type 2 diabetes mellitus patients with retinopathy,’’ T Klin J Med Res, 18, 6-9 (2000).
  • Ulusal
    D9. Çakır, M., G. Uslu, H. Altunbaş ve Ü. Karayalçın, ‘’Lithium Intoxication in Type 2 Diabetic patient after concurrent use of lisinopril and lithium,’’ T J E M, 1, 37-39 (2002).
  • Ulusal
    D10. Sarı, R., M.K. Balcı, H. Altunbaş, B. Kılınçarslan ve G. Karagüzel, ‘’Primer amenore ile başvuran miks gonadal disgenezis: olgu sunumu,’’ T Klin Tıp Bilimleri, 22, 305-307 (2002).
  • Ulusal
    D11. Çakır, M., B. Kılınçarslan, E.İ. Gürer, C. Arıcı, H. Altunbaş, R. Sarı, G. Karpuzoğlu ve Ü. Karayalçın, ‘’Concurrent Metastatic Paraganglioma and Follicular Thyroid Carcinoma,’’ T J E M, 1, 49-52 (2003).
  • Ulusal
    D12. Çakır, M., Ö. Gencel, D. Kaplangı, M.K. Balcı, Ö. Tosun, O. Saka, H. Altunbaş ve Ü. Karayalçın, ‘’Revised criteria for diagnosing diabetes- rational or not?,’’ T J E M, 3, 101-105 (2004).
  • Ulusal
    D13. Eray, E., B. Afacan, R. Sarı, H. Altunbaş, G. Yazıcıoğlu, M.K.Balcı, O. Eray ve Ü.Karayalçın, ‘’The clinical features of patients admitted to Akdeniz University School of Medicine Endocrinology Department with Hypoglycemia,’’ T J E M, 1: 9-11 (2005).
  • Ulusal
    D14. Altunbaş, H., ‘’İnkretin bazlı tedavilerin Tip 2 diabet tedavi algoritmalarındaki yeri,’’ Diabet Bilimi 9(1) 27-32 (2011).
  • Ulusal
    D15. Altunbaş, H., ‘’Gebelik ve Prolaktinoma,’’ Türkiye Klinikleri J Endocrin-Special Topics 5(2): 62-66 (2012).
  • Ulusal
    D16. Damcı, T., Ş.İmamoğlu, T.Balkır, SOLVE Türkiye Çalışma Grubu (- H.Altunbaş), ‘’Oral antidiabetik ilaçla tedavi edilen tip 2 diabet hastalarında günde bir kez bazal insülin analoğu tedavisinin güvenliliğinin değerlendirildiği 24 haftalık, çokmerkezli gözlem çalışması: SOLVE çalışması Türkiye Sonuçları,’’ Diabet Bilimi 10(1): 3-10 (2012).
  • Ulusal
    D17. Koyuncu, B.Ü., H.Altunbaş, E.İ.Gürer, Ü.Karayalçın, ‘’34-year-old male with hashimoto thyroiditis and primary thyroid lymphoma,’’ Türkiye Klinikleri Endokrinoloji Dergisi 8(1) 39-42 (2013).
  • Ulusal
    D18. Dinçkan, A., H.Koçak, H.Altunbaş, ‘’Pankreas ve Adacık Hücre Transplantasyonu,’’ Türkiye Klinikleri Genel Cerrahi Transplantasyon Özel Sayısı 6(1) 112-117 (2013).
  • Ulusal
    D19. Balcı, M.K., H. Altunbaş, T. Gelen, F. Çiftçi ve Ü. Karayalçın, ‘’Nekrobiozis Lipoidika Diabetikorum tespit edilen NIDDM'lu bir hasta,’’ Türk Diabet Yıllığı, 12, 218-220 (1996-1997).
  • Ulusal
    D20. Üstün, H., S. Akça, H. Altunbaş, H. Bozcuk, F. Çiftçi ve M.K. Balcı, ‘’EKG'de düzeltilmiş QT ile Tip II Diabetes Mellitus'un komplikasyonları arasındaki ilişki,’’ Türk Diabet Yıllığı, 12, 193-195 (1996-1997).
  • Ulusal
    D21. Balcı, N., M.K. Balcı ve H. Altunbaş, ‘’Tip I ve II Diabetik Hastalarda Omuz Adeziv Kapsuliti,’’ Endokrinolojide Yönelişler, 7(4), 119-122 (1998).
  • Ulusal
    D22. Arıcı, C., B. Mayır, H. Altunbaş, A. Boz, R. Sarı, B. Karayalçın, M.K. Balcı, Ü. Karayalçın, ‘’Primer hiperparatiroidizmde lokalizasyon yöntemleri ve tedavi,’’ Endokrinolojide Diyalog, 4, 225-230 (2005).
  • Ulusal
    D23. Arıcı, C., E. Peştereli, H. Altunbaş, A. Mesci, Ü. Karayalçın, T.Karpuzoğlu, ‘’Anaplastic thyroid cancer presenting with thyrotoxicosis and hyperactive thyroid nodule: case report and literature review,’’ Endokrinolojide Diyalog, 2, 93-95 (2006).
  • Ulusal
    D24. Arıcı, C., B. Mayır, H. Altunbaş, M.K. Balcı ve Ü. Karayalçın, ‘’Paratiroid Kanseri,’’ Endokrinolojide Diyalog 1, 44-47 (2006).
  • Ulusal
    D25. Mesci, A., A.Dinçkan, T.Çolak, H.Altunbaş, M.K. Balcı, C. Arıcı, ‘’Laparoskopik adrenalektomi; genel cerrahi kliniğindeki ilk deneyimler,’’ Endokrinolojide Diyalog, 3, 137-138 (2008).
  • Ulusal
    D26. Altunbaş, H., ‘’Akut primer adrenal yetmezlikler ve tedavisi: Primer adrenal yetmezlik, bilateral adrenal hemoraji ve infarktüs,’’ T Klin Journal of Endocrinology, ‘’Addison Hastalığı’’ özel sayısı, 2(1), 26-30 (2009).
  • Ulusal
    D27. Sarı, R., H. Altunbaş ve Ü. Karayalçın, ‘’Pankreas Organ Nakli,’’ Endokrinolojide Yönelişler 18(4), 133-135 (2009).
  • Ulusal
    D28. Altunbaş, H., ‘’Diabetes Mellitus ve Bağışıklık Sistemi,’’ Türk Diabet Yıllığı (2009-2010).
  • Ulusal
    D29. Şanlıoğlu, A.D., H. Altunbaş, M.K.Balcı, S.Şanlıoğlu, ‘’Tip 1 diabetli hastalarda insülin tedavisinde ve insülin gen terapisinde güncel gelişmeler,’’ Klinik Tıp Aile Hekimliği Diyabet Özel sayısı 5(2): 33-38 (Mart-Nisan 2013).
  • Ulusal
    D30. Altunbaş, H., ‘’Tip 1 diyabette adacık ve kök hücre tedavileri,’’ Diyabet ve sağlıklı yaşam Sayı 75, Ağustos 2026: 30-33.
Publications
  • 92 ulusal bilimsel toplantıda sunulan ve bildiri kitabında basılan bildiri (E1–E92)
  • 3 kitap bölümü çevirisi: Nefroloji El Kitabı, İç Hastalıkları Olgu Kitabı, Gastroenteroloji El Kitabı (Manual of Gastroenterology)
  • TURDEP-II ve TURNEP çok merkezli ulusal çalışma gruplarında araştırmacı — diabetes/prediabetes prevalansı ve diyabetik periferik nöropati
  • Harvard Medical School, Joslin Diabetes Center, Boston (2007) — kapsüllenmiş adacıklarda hücresel bileşim değişiklikleri araştırması
  • Nodüler guatrın nonoperatif tedavisinde tiroid embolizasyonu — J Vasc Interv Radiol 2021
  • Tip 1 diyabette beta-hücre rejenerasyonu ve GLP-1/VIP gen tedavisi yaklaşımları üzerine derlemeler (Expert Rev Mol Med, Gene Ther, Hum Gene Ther)
  • Akdeniz Üniversitesi Tıp Fakültesi Endokrinoloji ve Metabolizma Bilim Dalı Başkanlığı (2012–2014) ve Rektör Danışmanlığı (2015–2019)